Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9338 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.9034 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9034 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9013 |
High Similarity |
NPD7411 |
Suspended |
0.8993 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8987 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8973 |
High Similarity |
NPD1549 |
Phase 2 |
0.8917 |
High Similarity |
NPD6959 |
Discontinued |
0.8824 |
High Similarity |
NPD4380 |
Phase 2 |
0.8782 |
High Similarity |
NPD7768 |
Phase 2 |
0.8742 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8726 |
High Similarity |
NPD7075 |
Discontinued |
0.8654 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8654 |
High Similarity |
NPD7819 |
Suspended |
0.8589 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8535 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD6166 |
Phase 2 |
0.8514 |
High Similarity |
NPD1510 |
Phase 2 |
0.8491 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8456 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8367 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8354 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8354 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8289 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8255 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8204 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8199 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8144 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8095 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8077 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8077 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8077 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8059 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8038 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8013 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8012 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8012 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7987 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7963 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7941 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7917 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7895 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7888 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7866 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7857 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7853 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7852 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7844 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7824 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7821 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7805 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7746 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7719 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7684 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7673 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7593 |
Intermediate Similarity |
NPD920 |
Approved |
0.758 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7578 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7578 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7578 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7564 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7516 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3226 |
Approved |
0.75 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7484 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.746 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7438 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7433 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7433 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7405 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7405 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7405 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD943 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7293 |
Intermediate Similarity |
NPD4287 |
Approved |
0.729 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7287 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7287 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7287 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7283 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7257 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7251 |
Intermediate Similarity |
NPD919 |
Approved |
0.725 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7219 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7189 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7189 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7168 |
Intermediate Similarity |
NPD1247 |
Approved |
0.716 |
Intermediate Similarity |
NPD2654 |
Approved |
0.716 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7101 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD4288 |
Approved |
0.707 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7069 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7062 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7053 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7033 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7026 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7 |
Intermediate Similarity |
NPD9545 |
Approved |
0.6995 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD8005 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD3972 |
Approved |
0.6989 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD3266 |
Approved |
0.6968 |
Remote Similarity |
NPD1470 |
Approved |
0.6968 |
Remote Similarity |
NPD3267 |
Approved |
0.6966
|
Remote Similarity |
NPD7228 |
Approved |